Sunitinib enhances the antitumor responses of agonistic CD40-antibody by reducing MDSCs and synergistically improving endothelial activation and T-cell recruitment

被引：0
|
作者：
van Hooren, Luuk
Georganaki, Maria
Huang, Hua
Mangsbo, Sara
Dimberg, Anna
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-1485
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1485
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Sunitinib enhances the antitumor responses of agonistic CD40-antibody by reducing MDSCs and synergistically improving endothelial activation and T-cell recruitment
    van Hooren, Luuk
    Georganaki, Maria
    Huang, Hua
    Mangsbo, Sara M.
    Dimberg, Anna
    ONCOTARGET, 2016, 7 (31) : 50277 - 50289
  • [2] STING and TLR-independent activation of T-cell responses against pancreatic cancer using agonistic CD40 antibody
    Byrne, Katelyn T.
    Morrison, Alexander H.
    Vonderheide, Robert H.
    CANCER RESEARCH, 2019, 79 (24)
  • [3] Anti-OX40 agonistic antibody enhances ex vivo CD8+ TIL expansion with increased T-cell effector function
    Ritthipichai, Krit
    Machin, Marcus
    Fardis, Maria
    Chartier, Cecile
    CANCER RESEARCH, 2018, 78 (13)
  • [4] IgE enhances specific antibody and T-cell responses in mice overexpressing CD23
    Carlsson, F.
    Hjelm, F.
    Conrad, D. H.
    Heyman, B.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2007, 66 (2-3) : 261 - 270
  • [5] Anti-CD40 antibody enhances responses to polysaccharide without mimicking T cell help
    de Vinuesa, CG
    MacLennan, ICM
    Holman, M
    Klaus, GGB
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1999, 29 (10) : 3216 - 3224
  • [6] THE ROLE OF T-CELL ACTIVATION IN ANTI-CD3 X ANTITUMOR BISPECIFIC ANTIBODY THERAPY
    WEINER, GJ
    KOSTELNY, SA
    HILLSTROM, JR
    COLE, MS
    LINK, BK
    WANG, SL
    TSO, JY
    JOURNAL OF IMMUNOLOGY, 1994, 152 (05): : 2385 - 2392
  • [7] Targeting human CD27 with an agonist antibody stimulates T-cell activation and antitumor immunity
    Thomas, Lawrence J.
    He, Li-Zhen
    Marsh, Henry
    Keler, Tibor
    ONCOIMMUNOLOGY, 2014, 3 (01)
  • [8] The CD40 agonistic antibody APX005M 'licenses' antigen presenting cells to promote tumor-specific T-cell responses
    Filbert, Erin L.
    Bjorck, Pia
    Yang, Xiaodong
    Trifan, Ovidiu C.
    CANCER RESEARCH, 2016, 76
  • [9] Nonredundant roles for immune checkpoint blockade and agonistic CD40 in mediating T-cell responses in pancreatic ductal adenocarcinoma
    Morrison, Alexander H.
    Byrne, Katelyn T.
    Vonderheide, Robert H.
    CANCER RESEARCH, 2018, 78 (13)
  • [10] In-situ vaccination using focused ultrasound heating and anti-CD-40 agonistic antibody enhances T-cell mediated local and abscopal effects in murine melanoma
    Singh, Mohit Pratap
    Sethuraman, Sri Nandhini
    Ritchey, Jerry
    Fiering, Steven
    Guha, Chandan
    Malayer, Jerry
    Ranjan, Ashish
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2019, 36 : 64 - 73
12345